Excipient Impurity Analysis
Excipient Impurity Analysis is a systematic analytical methodology within pharmaceutical science that identifies, characterizes, and quantifies unintended residual or degradative substances in excipients to ensure their safety, quality, and compliance with regulatory standards.
10
Publications
260
Citations
66
Authors
32
Institutions
Publications per year
2017–2026
1
Parents
10
Elemental Impurities in Pharmaceutical Excipients
Gang Li, D.R Schoneker, Katherine L. Ulman et al. · Journal of Pharmaceutical Sciences · 2015 · 67 citations · Full text
S. A. Wissing, Duncan Q.M. Craig, S. A. Barker et al. · International Journal of Pharmaceutics · 2000 · 39 citations
Trends in Excipient Safety Evaluation
Robert E. Osterberg, C.C DeMerlis, David W. Hobson et al. · International Journal of Toxicology · 2011 · 24 citations
1–5 of 10
66
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 66
32
Harley-Davidson (United States)
Milwaukee, United States
2 h-index
2 publications
91 citations
Corning (United States)
Corning, United States
1 h-index
3 publications
201 citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
1 h-index
2 publications
42 citations
Roche (Switzerland)
Basel, Switzerland
1 h-index
1 publications
21 citations
Takeda (Ireland)
Wicklow, Ireland
1 h-index
1 publications
21 citations
MSD (Netherlands)
Amsterdam, The Netherlands
1 h-index
3 publications
63 citations
IPEC-Americas
Arlington, United States
1 h-index
2 publications
134 citations
Novartis (United States)
New York, United States
1 h-index
2 publications
42 citations
1–8 of 32
2 publications · 88 citations
2
h-index
3 publications · 40 citations
2
h-index
1 publications · 47 citations
1
h-index
1 publications · 10 citations
1
h-index
1 publications · 39 citations
1
h-index
1–5